Search for Clinical Trial Results

Mycosis Fungoides - 29 Studies Found
Status | Study |
Completed |
Study Name: Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides Condition: Mycosis Fungoides Date: 2005-09-07 Interventions: Drug: mechlorethamine-MCH (nitrogen mustard) All affected areas (lesions) are to be treated once daily f |
Terminated |
Study Name: Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides Condition: Mycosis Fungoides Date: 2007-07-02 Interventions: Device: Low-dose total skin electron beam therapy (4 Gy) |
Not yet recruiting |
Study Name: Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides Condition: Mycosis Fungoides Date: 2016-10-18 Interventions:
|
Withdrawn |
Study Name: Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides. Condition: Mycosis Fungoides Date: 2005-09-13 Interventions: Drug: CPG 7909 |
Completed |
Study Name: An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides Condition: Mycosis Fungoides Date: 2007-09-24 Interventions: Drug: 0.04% Mechlorethamine gel Mechlorethamine 0.04% PG applied to affected skin areas (lesions) once d |
Active, not recruiting |
Study Name: PUVA Maintenance Therapy in Mycosis Fungoides Condition: Patch/Plaque Stage Mycosis Fungoides Date: 2012-05-09 Interventions: Drug: 8-methoxypsoralen 8-methoxypsoralen 10mg per 20 kg body weight 1 hour before UVA exposure |
Recruiting |
Study Name: Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma Condition: Mycosis Fungoides Date: 2014-11-07 Interventions: Drug: Valchlor Valchlor gel 0.016% Other Name: Mechl |
Recruiting |
Study Name: Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome Condition:
Date: 2005-09-07 Interventions: Drug: alemtuzumab |
Terminated |
Study Name: Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome Condition:
Date: 2005-08-08 Interventions: Drug: HuMax-CD4 (zanolimumab) Monoclonal Antibody, 12 weekly infusions. |
Terminated |
Study Name: PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides Condition: Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Date: 2008-02-28 Interventions:
|